Welcome to our dedicated page for Enfusion news (Ticker: ENFN), a resource for investors and traders seeking the latest updates and insights on Enfusion stock.
Enfusion, Inc. (symbol: ENFN) is a pioneering provider of cloud-based portfolio management and risk systems, headquartered in Chicago, Illinois. With branch offices in New York, as well as wholly-owned subsidiaries in London and Hong Kong, Enfusion stands at the forefront of delivering innovative solutions to clients within the financial services industry. Their advanced software as a service (SaaS) platform empowers investment managers by unifying mission-critical systems and providing a single dataset for real-time performance, risk calculations, and accounting of complex financial products.
Enfusion's core business revolves around transforming the investment management industry by eliminating technology and information barriers, allowing investment managers to make informed decisions swiftly and efficiently. The company's solutions simplify investment and operational workflows, coalescing data into a single source of truth. This integrated approach helps clients manage over $90 billion in assets across some of the world's largest and most respected hedge funds.
Enfusion's recent achievements highlight its exceptional growth trajectory. The company has expanded its operations significantly, with maximum revenue generation from the Americas, followed by Asia Pacific and Europe, the Middle East, and Africa. Their innovative platform is trusted by numerous global clients for its real-time performance and robust risk management capabilities.
Enfusion continues to innovate and refine its offerings. Some of their current projects include enhancing their cloud-based solutions to further streamline investment processes and improve data accuracy. The company also emphasizes strong partnerships and collaboration with other industry leaders to bring the latest technological advancements to their clients.
Financially, Enfusion is on solid footing, experiencing rapid growth and affirming its position as a leader in the investment management software industry. The company's client base spans across the globe, relying on Enfusion's cutting-edge solutions to navigate the complexities of financial management.
Overall, Enfusion, Inc. is a crucial player in the financial services industry, known for its commitment to innovation, client satisfaction, and delivering value through state-of-the-art technology.
Enfusion, a leader in cloud-based investment management software, reported a 38% year-over-year revenue growth, reaching $36.5 million for Q2 2022. Despite strong performance, the company posted a net loss of $(4.1) million, impacted by $7.7 million in stock-based compensation. Adjusted EBITDA was $5.4 million, with an adjusted margin of 14.9%. Notably, the Net Dollar Retention Rate improved to 121.9%. The company added 50 new clients, bringing the total to 793, and introduced Enfusion Express for smaller fund managers. Guidance for Q3 is $38-$39 million in revenue.
Enfusion, Inc. (NYSE: ENFN) has launched Enfusion Express, a SaaS order and execution management system aimed at smaller fund managers with less than
Enfusion, a provider of cloud-native software-as-a-service solutions for investment managers, will report its second quarter fiscal year 2022 financial results on August 9, 2022, after U.S. market close. A conference call will follow at 2:00 PM PT / 5:00 PM ET to discuss results and provide financial guidance. Enfusion's platform integrates front-, middle-, and back-office teams, serving over 750 investment managers globally from ten offices. A live webcast of the call will be available on their investor relations website.
DataArt has secured a $75 million minority growth investment from FTV Capital, marking a significant milestone following its record revenue growth in 2021, which exceeded $290 million. This funding aims to enhance DataArt's global delivery capabilities and innovate in cloud and data software services. Despite the geopolitical risks, the firm demonstrated resilience by hiring over 870 new employees in 2022 and relocating 1,300 staff due to the Ukraine conflict, ensuring uninterrupted service delivery.
Zoovu, an AI-driven e-commerce platform, has secured
Enfusion, Inc. (NYSE: ENFN) has announced over 100 enhancements to its Order and Execution Management System (OEMS) in Q1 2022, reflecting a growing demand for SaaS-based solutions among asset managers facing market volatility and fee compression. Notably, OEMS bookings surged to 46% of total bookings, up from 25% year-on-year. Key upgrades include expanded fixed income support, improved broker defaults, and enhanced order functionalities for IRS and CDX. These enhancements aim to optimize operations for investment managers, making the platform suitable for a broader array of asset management strategies.
FTV Capital has appointed Kapil Venkatachalam as partner, focusing on investments in B2B software and technology-enabled services. This move follows FTV's successful close of a
Enfusion, Inc. (NYSE: ENFN) reported a 40% year-over-year revenue increase for Q1 2022, reaching $34.1 million, driven by strong client demand. The company added 42 new clients, achieving record contract values, including two seven-figure deals. However, the net income was $(12.5) million, influenced by $12.7 million in stock-based compensation. Total Annual Recurring Revenue (ARR) increased to $137.6 million, a 37% rise from the previous year. The company anticipates Q2 2022 revenues between $35 million and $36 million, with full-year guidance of $148.1 million to $151.1 million.
Northern Trust and Enfusion have established a partnership to enhance operational efficiency for mutual clients by integrating their services. This collaboration aims to streamline portfolio management, order execution, and analytics, providing an end-to-end solution for asset managers and hedge funds. Enfusion’s cloud-native platform removes operational barriers, enabling seamless data access across front, middle, and back offices. The partnership also includes a certified interface co-developed with Equity Data Science, demonstrating a commitment to delivering innovative financial services.
FAQ
What is the current stock price of Enfusion (ENFN)?
What is the market cap of Enfusion (ENFN)?
What does Enfusion, Inc. do?
Where is Enfusion headquartered?
What is Enfusion's core business focus?
How much in assets do Enfusion's clients manage?
In which regions does Enfusion generate the most revenue?
What recent achievements has Enfusion made?
What kind of clients does Enfusion serve?
How does Enfusion simplify investment and operational workflows?
What are some current projects Enfusion is working on?
What is Enfusion's market position?
